Rosacea Awareness Month News: Study Explores the Role of CGRP-inhibition in Rosacea-related Redness
Erenumab (Aimovig, Novartis and Amgen) an anti–calcitonin gene-related peptide (CGRP)-receptor monoclonal antibody may improve rosacea-associated erythema and flushing, a new study suggests. In the single-group, 12-week, nonrandomized controlled trial of 30 individuals with rosacea-associated erythema and flushing, subcutaneous injections of erenumab administered every four weeks for 12 weeks significantly reduced days with flushing and erythema […]